Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-04-06

Clinical Trial Update: Reinfection and Long Term Outcomes in Intravenous Drug Users (IVDUs) After Hepatitis C Treatment

View source ↗

Summary

A clinical trial update examining reinfection rates and long-term outcomes after Hepatitis C treatment in people who inject drugs.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Pennine Acute Hospitals NHS Trust | Conditions: Hepatitis C | Status: UNKNOWN